AIkido Pharma (AIKI) Competitors $6.24 +0.53 (+9.28%) As of 10/13/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. LUNA, DKDCA, PEPG, FATE, CCCC, BHST, ACHV, CGEN, BMEA, and AVRShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Luna Innovations (LUNA), Data Knights Acquisition (DKDCA), PepGen (PEPG), Fate Therapeutics (FATE), C4 Therapeutics (CCCC), BioHarvest Sciences (BHST), Achieve Life Sciences (ACHV), Compugen (CGEN), Biomea Fusion (BMEA), and Anteris Technologies Global (AVR). AIkido Pharma vs. Its Competitors Luna Innovations Data Knights Acquisition PepGen Fate Therapeutics C4 Therapeutics BioHarvest Sciences Achieve Life Sciences Compugen Biomea Fusion Anteris Technologies Global Luna Innovations (NASDAQ:LUNA) and AIkido Pharma (NASDAQ:AIKI) are both small-cap commercial physical research industry companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends. Do insiders and institutionals hold more shares of LUNA or AIKI? 87.5% of Luna Innovations shares are held by institutional investors. Comparatively, 10.9% of AIkido Pharma shares are held by institutional investors. 7.6% of Luna Innovations shares are held by insiders. Comparatively, 8.6% of AIkido Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is LUNA or AIKI more profitable? Luna Innovations' return on equity of 0.00% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Luna InnovationsN/A N/A N/A AIkido Pharma N/A -18.21%-16.94% Which has more risk and volatility, LUNA or AIKI? Luna Innovations has a beta of 2.04, meaning that its share price is 104% more volatile than the S&P 500. Comparatively, AIkido Pharma has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Which has preferable earnings and valuation, LUNA or AIKI? Luna Innovations has higher revenue and earnings than AIkido Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLuna Innovations$116.61M0.35$9.28MN/AN/AAIkido PharmaN/AN/A-$7.17M-$3.88-1.61 Does the media refer more to LUNA or AIKI? In the previous week, Luna Innovations' average media sentiment score of 0.00 equaled AIkido Pharma'saverage media sentiment score. Company Overall Sentiment Luna Innovations Neutral AIkido Pharma Neutral SummaryLuna Innovations beats AIkido Pharma on 6 of the 7 factors compared between the two stocks. Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIKI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.23M$27.00M$6.04B$10.45BDividend YieldN/AN/A5.73%4.82%P/E Ratio-1.61N/A85.1427.26Price / SalesN/A0.35590.92134.18Price / CashN/A57.2325.7730.18Price / Book0.320.3212.666.76Net Income-$7.17M-$525K$3.32B$276.50M7 Day Performance-15.90%59.22%0.44%0.88%1 Month Performance-4.88%90.80%9.35%8.17%1 Year Performance244.75%51.58%79.07%43.52% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$6.24+9.3%N/A+205.3%$34.23MN/A-1.614High Trading VolumeLUNALuna InnovationsN/A$1.13+2.7%N/A-38.4%$38.37M$116.61M0.00390Gap UpDKDCAData Knights AcquisitionN/A$1.03-1.0%N/A+375.8%$5.33MN/A-5.422Gap UpHigh Trading VolumePEPGPepGen3.46 of 5 stars$4.91-1.0%$8.40+71.1%-48.4%$162.69MN/A-1.6630FATEFate Therapeutics3.8206 of 5 stars$1.39-1.4%$3.30+137.4%-55.0%$162.62M$13.63M-0.96550CCCCC4 Therapeutics3.6418 of 5 stars$2.26-0.9%$8.50+276.1%-61.4%$162.27M$35.58M-1.43150BHSTBioHarvest Sciences1.7205 of 5 stars$11.67+18.5%$13.67+17.1%N/A$161.79M$25.19M-16.67N/AGap UpHigh Trading VolumeACHVAchieve Life Sciences2.4484 of 5 stars$3.32+5.1%$12.00+261.4%-38.0%$161.49MN/A-2.2720CGENCompugen1.3265 of 5 stars$1.76-1.7%$4.00+127.3%+30.2%$159.74M$27.86M-8.0070News CoverageBMEABiomea Fusion3.3147 of 5 stars$1.85-30.7%$9.50+413.5%-84.7%$158.89MN/A-0.6150High Trading VolumeAVRAnteris Technologies Global1.7863 of 5 stars$4.37-0.7%$16.50+277.6%N/A$158.67M$2.70M0.00138 Related Companies and Tools Related Companies Luna Innovations Alternatives Data Knights Acquisition Alternatives PepGen Alternatives Fate Therapeutics Alternatives C4 Therapeutics Alternatives BioHarvest Sciences Alternatives Achieve Life Sciences Alternatives Compugen Alternatives Biomea Fusion Alternatives Anteris Technologies Global Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
